A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease

INTRODUCTION: We and collaborators discovered that flickering lights and sound at gamma frequency (40 Hz) reduce Alzheimer's disease (AD) pathology and alter immune cells and signaling in mice. To determine the feasibility of this intervention in humans we tested the safety, tolerability, and d...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiliang, Colon‐Motas, Kay M., Pybus, Alyssa F., Piendel, Lydia, Seppa, Jonna K., Walker, Margaret L., Manzanares, Cecelia M., Qiu, Deqiang, Miocinovic, Svjetlana, Wood, Levi B., Levey, Allan I., Lah, James J., Singer, Annabelle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118113/
https://www.ncbi.nlm.nih.gov/pubmed/34027028
http://dx.doi.org/10.1002/trc2.12178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118113/
https://www.ncbi.nlm.nih.gov/pubmed/34027028
http://dx.doi.org/10.1002/trc2.12178

Ejemplares similares